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Tissue-resident memory T (Trm) cells constitute a recently identified lymphocyte lineage that occupies tis-
sues without recirculating. They provide a first response against infections reencountered at body surfaces,
where they accelerate pathogen clearance. Because Trm cells are not present within peripheral blood, they
have not yet been well characterized, but are transcriptionally, phenotypically, and functionally distinct from
recirculating central and effector memory T cells. In this review, we will summarize current knowledge of Trm
cell ontogeny, regulation, maintenance, and function and will highlight technical considerations for studying
this population.INTRODUCTION
The Phylogeny of Memory T Cell Subsets
Observations of phenotypic heterogeneity in the expression of
homing receptors by human memory CD8+ and CD4+ T cells
led to the conceptualization that memory T cells could be parsed
into two subsets, which were labeled central memory (Tcm) and
effector memory (Tem) cells (Sallusto et al., 1999). Importantly,
this analysis was done in blood. Because Tcm and Tem cells
not only expressed distinct homing receptors, but also unique
effector properties, it was conceived that immunosurveillance
patterns were intrinsically coupled with functional specialization.
Much like naive T cells, Tcm cells patrol secondary lymphoid
organs (SLOs), which include lymph nodes (LNs) and the white
pulp (WP) of spleen (Figure 1) (von Andrian and Mackay, 2000;
Sallusto et al., 1999). Also like naive T cells, after Ag-recognition
Tcm cells undergo rapid and robust proliferation, differentiate
into effector cells, and then migrate from SLOs to other tissues
in search of infections to eliminate (von Andrian and Mackay,
2000). Like recently stimulated effector T cells, upon antigen
recognition Tem cells remain poised for rapid execution of
certain effector functions, such as cytolysis of infected host cells,
rather than for proliferation. Tem cells also lack LN homing re-
ceptors (CD62L and CCR7), yet expressed distinct patterns of
other homing receptors, and on that basis it was proposed that
Tem cells recirculate between blood and nonlymphoid tissues
(NLTs) or remain poised to mobilize to sites of inflammation
(Butcher and Picker, 1996; Mackay et al., 1990; Sallusto et al.,
1999). Consistent with this model, memory T cells were
observed in many NLTs long after Ag clearance (Masopust
et al., 2001b; Reinhardt et al., 2001). These observations pro-
vided a justification for extrapolating observations from blood
Tem cells to T cells isolated from NLTs, which was convenient
because blood lymphocytes are far easier to sample.
However, some observations were not consistent with the
model that all NLT memory cells were recirculating Tem cells.
For instance, for T cells to recirculate through NLTs they must
enter from the blood and exit via afferent lymphatics. Elegant
work demonstrated paradoxically that CCR7 expression by
T cells might be required for egress from NLT (Bromley et al.,
2005; Debes et al., 2005). Because the absence of CCR7 expres-886 Immunity 41, December 18, 2014 ª2014 Elsevier Inc.sion was a defining feature of Tem cells, it was unclear how Tem
cells could recirculatebetweenNLTs, lymph,andblood.Addition-
ally, CD62L cells isolated fromblood and spleen did not recapit-
ulate the panoply of phenotypes expressed by memory T cells
isolated from the small intestinal mucosa, lung, and brain (Hawke
et al., 1998; Hogan et al., 2001; Kim et al., 1998; Masopust et al.,
2001a; van der Most et al., 2003). This prompted speculation that
memory T cells permanently resided within certain NLTs rather
than recirculate through blood (Masopust et al., 2001b).
These discrepancies were partly clarified upon the clear
demonstration that populations of memory T cells were settled
within many NLTs (Figure 1) (Gebhardt et al., 2009; Jiang et al.,
2012; Masopust et al., 2010; Teijaro et al., 2011; Wakim et al.,
2010). These tissue-resident memory T cells (abbreviated Trm
cells to distinguish them from Tcm and Tem cells) derived from
precursors that entered tissues during the effector phase of
immune responses and remained positioned within this
compartment. The identification of this memory T cell lineage
precipitated many new questions. How are Trm cells regulated?
When and how are they established? How are Trm cells main-
tained and for how long? How do they function and contribute
to protective immunity? This review will summarize basic con-
cepts in Trm cell biology, will draw attention to important tech-
nical considerations for their study, and will highlight remaining
gapswithin the field. It should be noted that the existing literature
is more developed for CD8+ rather than CD4+ Trm cells, and the
review will reflect this focus.
Trm Ontogeny
T cell recirculation is a dynamic and active process that is regu-
lated during all phases of immune responses (von Andrian and
Mackay, 2000; Masopust and Schenkel, 2013; Mueller et al.,
2013). Naive T cells enter SLOs from blood using a combination
of selectins, chemokines, and integrins, and then patrol for 12–
24 hr before leaving to explore other SLOs in their continuous
quest for cognate Ag (von Andrian and Mackay, 2000; von
Andrian and Mempel, 2003). Exiting SLOs is an active process
and depends on gradual T cell sensitization to sphingosine-1
phosphate receptor 1 (S1PR1)-dependent chemotactic gradi-
ents (Arnon et al., 2011; Lo et al., 2005; Shannon et al., 2012).




















Figure 1. T Cell Migration Patterns
T cell subsets exhibit distinct migration patterns. Like naive T cells, Tcm cells
recirculate between blood, the T cell zones of secondary lymphoid organs, and
lymph. Tem cells recirculate between nonlymphoid tissues, lymph, lymph
nodes (where they might pass through via the sinuses, without entering the
T cell zone), and blood. Trm cells do not recirculate but rather are confined to a
single tissue.
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like factor 2 (KLF2), a positive regulator of S1PR1 transcription
(Preston et al., 2013; Skon et al., 2013; Grayson et al., 2001).
S1PR1 downregulation is concomitantly associated with cell
surface expression of the C-type lectin CD69 (Cyster and
Schwab, 2012; Matloubian et al., 2004; Schober et al., 1999;
Shiow et al., 2006; Skon et al., 2013). This prevents very recently
activated T cells from leaving the SLO until they are fully primed.
It should be noted that cognate antigen recognition is not the
only signal that modulates CD69. For example, type I interferon
(IFN), interleukin-33 (IL-33), and tumor necrosis factor-a (TNFa)
and other cytokines all induce CD69 upregulation on T cells
(Casey et al., 2012; Kohlmeier et al., 2010; Lo´pez-Cabrera
et al., 1995; Skon et al., 2013). This increases the dwell time of
unactivated T cells within inflamed SLOs, putatively bettering
their chance of locating cognate Ag. Thus, routine T cell egress
from SLOs can be altered in the context of inflammation or anti-
gen recognition.
When naive T cells are productively primed within SLOs, they
give rise to effector cells that migrate throughout the host and
leave behind a memory population that persists long after path-
ogen clearance (Dutton et al., 1998; Harty and Badovinac, 2008;
Lefranc¸ois, 2006; Sallusto et al., 2010; Williams and Bevan,
2007). Memory T cells can be isolated from SLO, blood-borne
compartments, and NLTs (Masopust et al., 2001b; Reinhardt
et al., 2001; Woodland and Kohlmeier, 2009), and at least for
CD8+ T cells, this may include NLTs that were not sites of infec-
tion (Hofmann and Pircher, 2011; Kaufman et al., 2008; Liu et al.,
2006; Masopust et al., 2010; 2004; Zhu et al., 2012). Memory
CD8+ T cells in many NLTs lack CD62L (Casey et al., 2012),
the defining phenotype of a Tem cell. However, NLT-derived
memory T cells also express many markers not shared by anycirculating population of memory T cells within blood (Casey
et al., 2012; Gebhardt et al., 2009; Hawke et al., 1998; Hofmann
and Pircher, 2011; Jiang et al., 2012; Masopust et al., 2006; Ray
et al., 2004). It was difficult to reconcile this observation with the
model that NLT memory T cells were recirculating between
blood and tissue parenchyma.
Migration studies helped clarify this discrepancy. It was found
that only effector, and notmemory, CD8+ T cells were competent
to enter the small intestine, brain, or salivary gland (Hickey et al.,
1991; Hofmann and Pircher, 2011; Masopust et al., 2010; Wakim
et al., 2010). Moreover, T cell populations within NLT grafts were
not in equilibrium with host tissues when transplanted into
isogenic recipients (Gebhardt et al., 2009; Masopust et al.,
2010). And when the vasculature of two mice was conjoined
via parabiotic surgery, T cells did not equilibrate between the
skin epidermis, female reproductive tract, or lung of each mouse
(Iijima and Iwasaki, 2014; Jiang et al., 2012; Schenkel et al., 2013;
Teijaro et al., 2011). Taken together, these data indicate that
NLTs contained populations of memory T cells that were not in
circulation. Rather, they seeded NLTs during the effector phase
of the response, and then became permanently established
in situ (Hofmann and Pircher, 2011;Masopust et al., 2010). These
cells are now referred to as Trm.
Examining the dynamics of phenotypic changes among anti-
viral CD8+ T cells within the small intestinal mucosa provides
some insight into the ontogeny of Trm cells. After acute viral
infections in mice and humans, effector T cells transiently upre-
gulate a4b7 integrin, which facilitates migration into the small in-
testine (Campbell and Butcher, 2002; Liu et al., 2006; Masopust
et al., 2010). After acute viral infection in mice, a4b7 is rapidly
downregulated after trafficking to gut, suggesting that recently
arrived effector CD8+ T cells have lost capacity for re-entry after
ingress (Masopust et al., 2010). This loss of a4b7 is coupled with
the in situ upregulation of aeb7 integrin (ae is also referred to as
CD103) and CD69, the maintenance of granzyme B, and the
downregulation of Ly6C and CD122 expression (Masopust
et al., 2006). The functional significance of CD69 and aeb7
expression will be discussed later in the review. These data indi-
cate that many Trm cell phenotypic signatures are acquired only
after migration to destination tissues of residence.
This observation supports the hypothesis that phenotype is
inherently coupled with location and that NLT themselves might
play an instructional role in shaping Trm cell differentiation.
Indeed, when Trm cells are transferred from the intestinal mu-
cosa to blood and then reactivated to induce proliferation and
distribution throughout the host, daughter cells adopt the pheno-
typic signatures characteristic of their new environment (Maso-
pust et al., 2006). In other words, effector progeny that trafficked
back to the intestinal mucosa reacquired gut Trm cell-associated
signatures, while daughter cells isolated from SLOs differenti-
ated into recirculating Tcm (Masopust et al., 2006). Thus,
changes in location are tied to changes in phenotype. This sug-
gests that Trm cells, despite their effector-like phenotype, might
not be terminally differentiated. Important recent observations
showed that the precursors of Trm cell in the skin and small in-
testine are derived from less differentiated memory T cell precur-
sors that expressed low levels of KLRG1 (Figure 2) (Mackay
et al., 2013; Sheridan et al., 2014). Conversely, many recirculat-
ing memory T cells have lost the developmental capacity toImmunity 41, December 18, 2014 ª2014 Elsevier Inc. 887
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Figure 2. Memory T Cell Differentiation
Like Tcm cells, Trm cells derive from KLRG1 precursors in mice and are less
terminally differentiated. However, Trm cell differentiation is regulated by local
factors at sites of residence. KLRG1+ cells likely receivedmore stimulation, are
more terminally differentiated, and are capable of differentiating into Tem, but
not Trm cells. High amounts of cell division, inflammatory cytokines, and
antigen exposure ultimately result in T cell death or functional exhaustion.
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after restimulation andmigration to the intestinal mucosa (Maso-
pust et al., 2006). Principal component analyses revealed that
Trm cells exhibited starkly different transcriptional signatures
compared to naive T cells, Tcm and Tem cells, the latter being
quite similar to one another (Mackay et al., 2013). While multiple
Trm subsets might exist, a key finding was that Trm cells in
different tissues shared many transcripts in common suggesting
a core signature (Mackay et al., 2013). Many of these common-
alities might be tied to the mechanisms that mediate residence.
Mechanisms of Trm Maintenance
In order for Trm cells to be maintained within tissues, they must
adapt to local survival cues, resist shedding into the lumen at
mucosal epithelial surfaces, and ignore egress signals (Maso-
pust and Schenkel, 2013; Mueller et al., 2013). These mecha-
nisms and their regulation represent areas of active research
that have important implications for Trm cell longevity.
Epithelial cells are arranged in confluent layers that line body
surfaces and cavities. The adherens protein E-cadherin tethers
epithelial cells together via homophilic interactions that enable
tight junctions. The integrin aeb7, one marker associated with
Trm (Casey et al., 2012; Mackay et al., 2013; Wakim et al.,
2010), can also bind E-cadherin (Cepek et al., 1994). Indeed,
CD8+ T cells that are genetically deficient in aeb7 are able to
migrate to the small intestine epithelium, brain, and skin
epidermis, but are not retained (Casey et al., 2012; Mackay
et al., 2013; Scho¨n et al., 1999; Wakim et al., 2010). One interpre-
tation is that aeb7 allows CD8+ T cells to physically adhere to
E-cadherin expressed on epithelial cells. A non-mutually exclu-
sive alternative hypothesis is that aeb7 expression promotes
survival of CD8+ T cells, as aeb7+ CD8+ T cells express more
of the prosurvival protein Bcl-2 early after infection in the brain
and skin epidermis (Mackay et al., 2013; Wakim et al., 2010).888 Immunity 41, December 18, 2014 ª2014 Elsevier Inc.Dependence on aeb7 for maintenance might also be context
dependent. After oral infection with Listeria monocytogenes,
aeb7 is important for the accumulation of CD8+ T cells in the
small intestine epithelium but is dispensable for long-term main-
tenance (Sheridan et al., 2014).
Whether a CD8+ T cell requires aeb7 for maintenance likely
also depends on location and might even vary among different
types of epithelium. For example, even though memory CD8+
T cells express aeb7 in the small intestine lamina propria (LP),
it is not required for T cell retention (Casey et al., 2012). Interest-
ingly, E-cadherin is also expressed by memory CD8 T cells iso-
lated from the salivary gland, small intestine epithelium, lung,
skin, thymus, and brain and might contribute to maintenance
via homophilic E-cadherin interactions between Trm cells and
epithelial cells (Hofmann and Pircher, 2011; Mackay et al.,
2013; Wakim et al., 2012). Other integrins that bind extracellular
matrix proteins in the LP or basement membrane might also
retain Trm cells in different tissues. For instance, the integrin
a1b1 binds laminins and collagens and is highly expressed on
CD8+ Trm in the brain, small intestine, lung, and skin (Gebhardt
et al., 2009; Mackay et al., 2013; Ray et al., 2004; Wakim et al.,
2012). Some evidence indicates that the majority of putative
Trm cells in many organs do not even express aeb7 (Casey
et al., 2012; Schenkel et al., 2014a). To conclude, while aeb7
expression on Ag-experienced CD8 T cells might be strongly
indicative of residence, it is likely that many Trm do not depend
on, nor even express, aeb7.
S1PR1 mediates T cell egress in lymph nodes by inducing
chemotaxis to sphingosine-1-phosphate (S1P) present within
efferent lymph (Cyster and Schwab, 2012). S1P is also produced
by afferent lymphatic endothelial cells draining NLTs and is
important for mature dendritic cells to migrate to tissue-draining
lymph nodes (Czeloth et al., 2005; Lamana et al., 2011; Maeda
et al., 2007; Pham et al., 2010). Thus, inhibiting S1P responsive-
ness might represent an important checkpoint for generating
Trm (Figure 3). In support of this hypothesis, CD69 is induced
on Trm after they migrate to sites of residence (Mackay et al.,
2013; Masopust et al., 2006; Skon et al., 2013), and as
mentioned previously, CD69 antagonizes S1PR1. Importantly,
CD69 KO CD8+ T cells were not maintained in skin epidermis
or lungs (Lee et al., 2011; Mackay et al., 2013). It remains to be
determined whether all Trm require CD69, or whether other
means of S1PR1 inhibition are sufficient for Trm maintenance.
For instance, the transcription factor kruppel-like factor 2
(KLF2) is required for S1PR1 expression on T cells and once
Trm precursors seed NLTs, KLF2 is downregulated (Skon
et al., 2013). When S1PR1 is forcibly expressed on CD8+
T cells, Trm cells are reduced in NLTs (Skon et al., 2013). Taken
together, the downregulation of KLF2 and S1PR1 and the upre-
gulation of CD69 might both play functional roles in the develop-
ment and retention of Trm cells.
Theremight be other factors that promote residence and recir-
culation. Trm cells have reduced expression of another S1P re-
ceptor, S1PR5, and S1PR5 is regulated independently of KLF2
and CD69 (Mackay et al., 2013; Wakim et al., 2012). KLF2 pro-
motes other homing markers involved in recirculation, including
CCR7 expression (Carlson et al., 2006), which might promote
leukocyte egress fromNLT via CCL19+ andCCL21+ afferent lym-
phatics. Indeed, SLO T cells emigrate in a CCR7-dependent
Figure 3. Mechanisms of Memory T Cell Residence and
Recirculation
Trm cells express low levels of the transcription factor KLF2 and S1PR1 and
high levels of the C-type lectin CD69, which collectively prevent exit from the
tissue. Certain Trmpopulationswithinmucosal or epidermal epithelium require
aeb7 integrin for maintenance (ae is also referred to as CD103). Trm cells are
sometimes densely clustered in leukocyte aggregates that also contain
myeloid cells. In contrast, recirculating Tem cells enter tissues from blood
(typically from postcapillary venules) and express high amounts of KLF2 and
S1PR1, but do not express CD69, which allows them to emigrate via S1P+
draining afferent lymphatics. Presentation on lymphatic endothelium of CCR7
ligands, CCL19 and CCL21, might also promote egress of CCR7+ non-
lymphoid T cells.
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T cells can be isolated from ovine afferent lymph (Bromley et al.,
2005; Debes et al., 2005). Similarly, dendritic cells upregulate
CCR7 after activation in tissues, which then acts in concert
with S1PR1 to promote migration to downstream SLOs (Braun
et al., 2011; Czeloth et al., 2005; Lamana et al., 2011; Ohl
et al., 2004; Saeki et al., 1999). Thus, repression of ccr7 might
also be another means of maintaining Trm cells.
Many critical questions remain. What is the longevity of Trm
cells relative to recirculating T cell subsets? Unfortunately, there
are few long-term studies on the durability of T cell memory in hu-
mans, even in blood (Hammarlund et al., 2003; Nanan et al.,
2000; Van Epps et al., 2002), and tracking T cell memory in
NLTs is less tractable. Shorter-term studies in mice and rhesus
macaques revealed that tissue memory CD8+ T cells are rela-
tively stable for 300–700 days (Jiang et al., 2012; Kaufman
et al., 2008; Masopust et al., 2001b). It was not demonstrated
in these studies whether recirculating memory T cells migrate
to tissues to replenish Trm cells, which has been proposed for
lung airways (Ely et al., 2006), or whether Trm cells were self-sus-
taining. However, 168 days after parabiosis surgery, there was
little evidence of recirculating memory CD8+ T cell infiltration
into the skin, suggesting that at least for some tissues, Trm cells
might be maintained independently of recirculating memory
T cells (Jiang et al., 2012). Of course, Trm cell longevity might
vary considerably depending on the initial nature and site of
the priming infection or vaccine, as observed for humoral immu-
nity. Indeed, CD8+ and CD4+ T cell memory in the lung and lung
airways wanes within months after influenza infection, leading to
the loss of protective heterosubtypic immunity (Hogan et al.,
2001; Liang et al., 1994; Wu et al., 2014).Mechanisms of Trm Cell Differentiation
CD69 and granzyme B are signatures of recently stimulated
T cells. Because these signatures are also constitutively ex-
pressed by T cells within the intestinal mucosa, it was originally
proposed that mucosal T cells represented activated effectors
(Montufar-Solis et al., 2007). Ag-specific studies revealed that
bona fide memory T cells specific for acute infections shared
these effector-like properties, raising the possibility that Ag is
not required for maintenance of this effector-like phenotype
(Hogan et al., 2001; Masopust et al., 2006). When naive CD8+
T cells expand homeostatically within RAG-deficient hosts,
they disseminate into the intestinal mucosa in the absence of
cognate antigen stimulation, the infectious milieu, and even the
microbial flora, yet in each instance they still adopt their
effector-like phenotypic signature (Casey et al., 2012). Homeo-
statically expanded CD8+ T cells in the stomach, female repro-
ductive tract, salivary gland, pancreas, and heart also express
CD69 (and other Trm cell signatures including aeb7) (Casey
et al., 2012). And when effector CD8+ T cells migrate to nonspe-
cific inflammation in the skin or vaginal mucosa, they also upre-
gulated aeb7 without antigen, reinforcing the hypothesis that
regulation might be independent of continual cognate Ag stimu-
lation (Mackay et al., 2012). Taken together, it appears that local-
ization to certain NLTs is sufficient to drive adoption of specific
phenotypes, much like inductive cues that drivemonocyte differ-
entiation in the small intestine (Zigmond and Jung, 2013).
Nevertheless, these data do not preclude a role for persistent
Ag in shaping Trm cell differentiation. For instance, during
chronic viral infection, aeb7 expression is reduced on virus-spe-
cific CD8+ T cells within the small intestine, which might suggest
that local antigen recognition inhibits aeb7 expression (Casey
et al., 2012; Zhang and Bevan, 2013). However, the issue is far
from clear, because compelling evidence demonstrates that
CNS, PNS, and lung require local antigen recognition for the up-
regulation of aeb7 (Lee et al., 2011; Mackay et al., 2012; Wakim
et al., 2010). In one particularly elegant experiment, when antigen
recognition was blocked in the lungs of influenza-infected mice
using MHC-peptide specific antibodies, aeb7 and CD69 expres-
sion was reduced (Lee et al., 2011). This loss of CD69 and aeb7
expression was paired with a concomitant loss in antigen-spe-
cific lung CD8+ T cells. Thus, the importance of antigen in the
differentiation and maintenance of Trm cells might be tissue
dependent. Sites of pathogen replication might also influence
Trm cell differentiation and retention. For instance, a larger num-
ber of Trm cells within the female reproductive tract are induced
to express aeb7 after local inflammation compared to systemic
infection or in the presence of local inflammation (C¸uburu
et al., 2012; Li et al., 2008; Mackay et al., 2012; Shin and Iwasaki,
2012).
Evidence suggests that the cytokine milieu within tissues
might drive Trm cell signatures, although only a limited number
of signals have been defined thus far. Most definitively, trans-
forming growth factor b (TGF-b) has been shown to induce
aeb7 expression on Trm cell precursors (Casey et al., 2012;
Lee et al., 2011;Mackay et al., 2013; Sheridan et al., 2014; Zhang
and Bevan, 2013). In vitro culture with TGF-b induces aeb7
expression on primary effector CD8+ T splenocytes (but not
resting memory CD8+ T splenocytes) (Casey et al., 2012). How-
ever, this aeb7 upregulation was prevented by the addition of AgImmunity 41, December 18, 2014 ª2014 Elsevier Inc. 889
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many epithelial surfaces, including skin epidermis and small
intestine epithelium (Koyama and Podolsky, 1989; Yang et al.,
1999). Moreover, TGF-bR deficiency prevents CD103 upregula-
tion in the skin, lung, and small intestine (Casey et al., 2012; El-
Asady et al., 2005; Lee et al., 2011; Mackay et al., 2013; Sheridan
et al., 2014; Zhang and Bevan, 2013). Similarly, it has been
demonstrated that T cells infiltrating the TGF-b rich microenvi-
ronment of tumors also express aeb7 (Le Floc’h et al., 2007).
While CD4+ T regulatory cells express CD103 in response to
TGF-b, CD4+ Th1 T cells are often refractory to CD103 expres-
sion. Although it is uncertain whether this is related to a lack of
TGF-bR expression, responsiveness to TGF-b is clearly depen-
dent on T cell differentiation state (Li and Flavell, 2008). Indeed,
KLRG1+ recently activated CD8 T cells, which did not give rise to
CD103+ Trm, express less TGF-b receptor II (TGF-bRII) (Mackay
et al., 2013; Sheridan et al., 2014). KLRG1+ effectors are also
particularly vulnerable to apoptosis when treated with TGF-b
in vitro (Sanjabi et al., 2009). Thus whether a T cell upregulates
aeb7 in response to TGF-b is multifactorial and intrinsically linked
to differentiation state.
The cytokine mechanism(s) controlling KLF2 and the S1PR1-
CD69 axis in NLTs is less well understood. CD69 expression is
upregulated and KLF2 is downregulated on primary effector
CD8+ T cells after short term, ex vivo culture with IL-33, TNF-a,
and IFN-a and IFN-b, demonstrating that in vitro, cytokines
can partially recapitulate these signatures of the Trm cell pheno-
type (Casey et al., 2012; Skon et al., 2013). Further, it was shown
that inhibiting the PI(3)K-Akt pathway ameliorated cytokine-
induced downregulation of KLF2 and S1PR1, suggesting that
this signaling pathway might be important for Trm development
(Skon et al., 2013). It remains possible that different cytokines
might operate under different contexts for controlling KLF2 and
the S1PR1-CD69 axis.
Cytokines might regulate other aspects of Trm cell differentia-
tion and survival. The homeostatic cytokines IL-7 and IL-15 are
important for maintenance of recirculating memory T cells in
SLOs (Surh and Sprent, 2008). Do these cytokines also play a
role in Trm cell survival? Trm cells in the skin epidermis are
dependent on IL-15 (Mackay et al., 2013), whereas Trm cells
positioned within SLOs persisted in the absence of IL-15 (in
contrast to Tcm within SLOs) (Schenkel et al., 2014a). Thus,
cytokine regulation of Trm cell persistence might be complex,
varying between different tissues. Additional survival factors
might also play a role in Trm cell longevity. For example, CD8+
Trm cells in the skin might require the aryl hydrocarbon receptor
for long-term survival (Zaid et al., 2014). Defining the factors
mediating Trm cell maintenance will help provide insight into
leveraging Trm cells for clinical benefit, including vaccines. In
this regard, it will be crucial to determine whether the total num-
ber of Trm cells established within NLTs is tightly regulated, as it
appears to be for Tcm cells within LNs, or whether it is flexible, as
shown for Tem cells (Vezys et al., 2009).
Critical Barriers to Accurately Studying Trm
Multiparameter flow cytometry allows high-throughput func-
tional and phenotypic analyses of single cell suspensions. For
this reason, studies of Trm cells often utilize populations of cells
isolated from whole organs. One drawback of this approach is890 Immunity 41, December 18, 2014 ª2014 Elsevier Inc.that anatomic and spatial information is lost, an important
consideration given the potential heterogeneity of T cells within
different tissue compartments within NLTs. Another drawback
is that while interpretation is predicated on presumptions of
near complete leukocyte extraction, isolation might be inefficient
and biased toward certain organ compartments or T cell sub-
sets. Below, we will attempt to summarize how these issues
might particularly impede our understanding of Trm cell differen-
tiation, distribution, and immunosurveillance within NLT.
Organs are complex structures composed of distinct tissues,
extracellular matrices, and cell types organized for the purposes
of executing unified functions. Anatomic compartments, includ-
ing epithelium, lamina propria, submucosae, muscularis exter-
nae, blood and lymphatic vessels, and tertiary lymphoid organs,
represent distinct environments in which memory T cells survey
host cells for evidence of reinfection. Differences in cell types,
cytokine milieu, adhesion molecules, and extracellular matrix
proteins might all influence T cell migration and differentiation,
and different compartments within organs might contain distinct
memory T cell populations that become admixed when organs
are dissociated for single cell analyses.
The issue of admixing compartments might be particularly
confounding due to contamination from vascular compartments,
and this occurs despite efforts to remove blood-borne cells by
perfusion. Work from James Hogg prognosticated this important
technical issue when he reported that the ratio of neutrophils to
RBCs was 100-fold higher in lung capillaries than in large-bore
blood vessels (Hogg et al., 1994). This was explained by the
fact that neutrophils take 60–100 times longer than RBCs to
transit through pulmonary capillaries. Pulmonary capillaries are
narrow for a reason, andwhere narrowest, they aremost efficient
at allowing gas exchange between RBCs and the external envi-
ronment. Thus even RBCs undergo deformation to navigate
through this compartment. Neutrophils have a much greater
cell volume than RBCs, so navigation is much slower, and perfu-
sion is not completely effective to remove them. This issue
extends to lymphocytes as well (which have a 3-fold greater
volume than RBCs; 90 femtoliters versus 290 femtoliters
(Segel et al., 1981)). Following acute intraperitoneal LCMV chal-
lenge, up to 95% of memory CD8 T cells isolated from perfused
lung were derived from vasculature (Anderson et al., 2012). Lung
infections still resulted in 70% blood contamination for CD8
T cells after mTB (Anderson et al., 2014; Sakai et al., 2014) and
20% after RSV (Knudson et al., 2014). Vascular contamination
by CD4+ T cells is less than CD8+ T cells in models addressed
thus far (Anderson et al., 2014; Knudson et al., 2014; Teijaro
et al., 2011) but is still significant. Further, it should be noted
that when analyzing healthy resting lung, abundant neutrophils
and naive B and T cells can be extracted; these are 100%
derived from the vasculature compartment (Anderson et al.,
2014). Importantly, these issues extend to other organs, particu-
larly the liver and kidney (Anderson et al., 2014).
In animal models, this issue can be simply addressed using
in vivo intravascular-staining strategies (Galkina et al., 2005;
Muppidi et al., 2011; Scanlon et al., 2011), which abrogate the
need to perfuse. The advantage of intravascular staining is that
it refines understanding of leukocyte localization, which is essen-
tial for defining migration patterns. It also allows one to include
vascular populations in analyses; these marginated pools might
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unique functional contributions to local immune responses as do
Kupffer cells and natural killer T (NKT) cells within the liver sinu-
soids (Thomas et al., 2011). In fact, within lung, intravascular NKT
cells precipitate allergies (Scanlon et al., 2011) and intravascular
CD4 T cells produce IFN-g in vivo in response to mTB (Sakai
et al., 2014). Of course, intravascular staining won’t discriminate
between leukocytes within different locations within lung tissue,
including NLT parenchyma and high endothelial cell (HEV)-con-
taining inductive sites such as inducible bronchus-associated
lymphoid tissue, the latter which might contain naive lympho-
cytes at sites of inflammation.
Low cell yields, compared to SLOs, are a major impediment to
studyingNLT populations. However, these yieldsmight underes-
timate the number of lymphocytes in NLTs (Ganusov and De
Boer, 2007; Selby et al., 1984). Many methods exist for enzy-
matic and tissue dissociation but it is unclear whether any
method extracts all leukocytes. Moreover, NLT populations
might be particularly prone to death during lengthy or harsh pro-
cessing procedures, because they do not survive well in culture
(Brunner et al., 2001; Wakim et al., 2012). These issues might
impact distinct leukocyte populations to varying degrees, thus
distorting accurate representation of subsets. Moreover, tertiary
lymphoid organs (TLOs) and aggregate structures are heteroge-
neously distributed throughout NLTs andmight cause significant
sampling bias if investigations (e.g., in humans or nonhuman pri-
mates) are limited to small biopsies.
Pairing single cell suspension analyses with imaging offers a
powerful approach to overcome some of these critical barriers.
The obvious advantages of imaging include the capture of spatial
information, circumvention of the issue of isolation inefficiencies,
and this approach is less vulnerable to subset misrepresenta-
tion. Moreover, unlabeled tissue samples can be stored for
years, allowing for future staining and analyses, and there is
rarely a shortage of material (i.e., mouse mucosal tissues can
be cut into 100 or more thin sections). Limitations include the
fact that sample processing, data acquisition, and analysis is
time consuming, instrument sensitivity and antibody availability
might constrain phenotypic analyses, and fewer parameters
(typically 4–8) can be interrogated contemporaneously as
compared to flow cytometry. Moreover, approaches to identify
T cells of known specificity, such as in situ MHC tetramer stain-
ing, require significant expertise and reagents.
Lastly, Trm cells are defined bymigration properties. However,
stringent evaluation of in vivo recirculation involves sophisticated
approaches including photoreactivation of Tg mice or T cells
(Bromley et al., 2013; Ugur et al., 2014), tissue grafts (Gebhardt
et al., 2009;Masopust et al., 2010), lymphatic canulation (Mackay
et al., 1990), transfers of labeled T cells (Hofmann and Pircher,
2011; Masopust et al., 2004; 2010), and/or parabiotic surgery
(Iijima and Iwasaki, 2014; Jiang et al., 2012; Klonowski et al.,
2004; Schenkel et al., 2013). These techniques are often not
pragmatic or even possible in certain animal models or humans.
For this reason, truly validated markers (CD69 might not suffice)
could facilitate more confident and refined analyses of Trm cells.
Trm Cell Distribution within SLO
Trm cells have been almost exclusively studied within NLTs.
However, there is evidence that Trm cells might also be posi-tioned within SLOs. In human cadavers, it was recently shown
that 50%–80%of CD4+ andCD8+ T cells express CD69 in spleen
and LNs (Sathaliyawala et al., 2013) and CD69+ CD8+ T cells
included those with defined specificity for CMV and influenza
(Turner et al., 2014). Photoconvertable fluorescence approaches
have demonstrated a retained population of CD4+ T cells in
Peyer’s patches and mesenteric LNs that accumulated in
response to chronic antigen exposure (Ugur et al., 2014). These
included, but were not limited to, T follicular helper (Tfh) cells,
and expressed CD69 and low amounts of S1PR1 (Ugur et al.,
2014). Indeed, Tfh might represent a major resident population
of CD4+ T cells in SLOs, although they might be short-lived after
Ag clearance. After murine lung infections associated with de-
pots of residual antigen, there is evidence for retention of CD8+
T cells within draining mediastinal LNs, and CD69 and CD103
are expressed in these contexts (Takamura et al., 2010; Zammit
et al., 2006). These data suggest that prolonged antigen stimula-
tion might induce CD4+ and CD8+ Trm cells within SLOs.
There is also evidence for Trm cells in SLOs in the putative
absence of persistent antigen. Parabiosis experiments demon-
strated that 1%–5% of memory CD8+ T cells within spleen and
LNs are Trm cells after acute LCMV infection (Schenkel et al.,
2014a). These cells share many markers with Trm cells identified
in the small intestinal mucosa, including expression of CD69 and
low amounts of CD62L, Ly6C, the transcription factor Eomeso-
dermin, and CD122. Unlike recirculating memory CD8+ T cells,
SLO Trm cells were not dependent on IL-15 for survival.
Why would SLO contain Trm cells? CD8+ Trm cells exhibited
biased distribution to splenic marginal zone and LN sinuses
(Schenkel et al., 2014a), which often represent the initial sites
of microbial entry to these organs (Aoshi et al., 2009; Gonzalez
et al., 2010; Junt et al., 2007). T cell reactivation within these
LN barrier sites precipitates rapid detection, innate immune acti-
vation, and recruitment of CXCR3+ memory T cells, all of which
likely contribute to accelerating pathogen control (Kastenmu¨ller
et al., 2013; Sung et al., 2012). A network of natural killer (NK)
cells, gd T cells, and innate-like CD8+ T cells are also preposi-
tioned near lymph node sinuses, and when activated, prevent
systemic pathogen dissemination (Kastenmu¨ller et al., 2012;
Sheridan et al., 2013). Thus, occupation of SLO pathogen-entry
sites might be functionally analogous to Trm cell positioning
within frontline NLTs.
Trm Cell Function
In the event of reinfection, Tcm cells produce potent recall re-
sponses due to their high proliferative potential and ability to
produce abundant effector progeny capable of migrating to
sites of infection. However, microbes are most often encoun-
tered first at mucosal sites and other body surfaces. Thus, if
Tcm cells were the only memory T cell subset, then the host
would have to wait for pathogen-derived Ag to disseminate to
SLOs (much like the situation for naive individuals) or innate
inflammation induced recruitment (Nolz and Harty, 2014) before
mounting an anamnestic T cell response. This fails to capitalize
on the most immediate opportunity for pathogen control after
initial infection, which in the case of some pathogens might
be critical.
Because Trm cells occupy frontline sites of infection, they are
anatomically positioned to respond most immediately. SeveralImmunity 41, December 18, 2014 ª2014 Elsevier Inc. 891
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tions to protective immunity against local challenges (Gebhardt
et al., 2009; Iijima and Iwasaki, 2014; Jiang et al., 2012; Teijaro
et al., 2011). In one particularly striking example, hosts contain-
ing both Trm cells and recirculating memory T cells exhibited a
99.99% reduction in viral load 6 days after local vaccinia virus
infection compared to animals containing only recirculating
memory T cell (Jiang et al., 2012). In a model of influenza infec-
tion, it was shown that CD4+ Trm cell completely protected
mice from lethal respiratory lung infection (Teijaro et al., 2011).
Indeed, many different pathogen challenge models have shown
that Trm cells mediate protection in a number of different organs
(Ariotti et al., 2014; Gebhardt et al., 2009; Jiang et al., 2012;
Mackay et al., 2012; Schenkel et al., 2014b; Shin and Iwasaki,
2012; Teijaro et al., 2011; Wu et al., 2014).
How are Trm cells able to effectively protect the host? Trm
cells must scan host cells for evidence of reinfection and employ
a variety of mechanisms to more efficiently detect pathogen.
During inflammatory tissue conditions, T cell motility in the
dermis increases 5 fold and utilizes avb1 and b3 binding to
fibronectin (Overstreet et al., 2013). Blocking integrin av results
in increased parasite burden during local Leishmania major
infection, suggesting that increased T cell motility is in important
for pathogen control (Overstreet et al., 2013). Chemokines also
affect T cell motility. In the brains of Toxoplasma gondii-infected
mice, CXCL10 expression increases the speed of local CD8
T cells (Harris et al., 2012). Moreover, T. gondii-specific T cells
do not scan host brain cells via random Brownian motion, but
rather move in what are known as Levy walks, greatly increasing
their ability to detect pathogen (Harris et al., 2012). Additionally,
CD8+ Trm cells in the epidermis are able to adopt a ‘‘dendritic-
like’’ morphology, allowing them to scan multiple host cells at
once for pathogen and thus maximizing their ability to locate
infected cells (Ariotti et al., 2012; Gebhardt et al., 2011). In sum-
mary, T cells regulate their motility, directionality, and mor-
phology to optimize pathogen detection.
Once T cells recognize infected cells, they employ a number of
mechanisms to clear pathogen. Memory CD8+ T cells in certain
NLT maintain constitutive granzyme B expression and like
recently activated effectors, mediate ex vivo cytotoxicity (Kim
et al., 1998; Masopust et al., 2006). Rapid delivery of cytotoxic
molecules represents one potential mechanism to eliminate
anamnestic infections. However, T cells might also clear patho-
gens through noncytolytic means. For example, the antiviral
cytokine IFN-g is critical for clearing L. major, HSV-2, and HBV
infections (Guidotti et al., 1996; Iijima et al., 2008; Mu¨ller et al.,
2012). Additionally, IFN-g effects are not limited to infected
host cells that T cells contact directly, but can also act on neigh-
boring infected host cells (Mu¨ller et al., 2012). Other mechanisms
of noncytolytic viral control exist. For instance, CD8+ T cells
maintain HSV-1 viral latency by secreting lytic granules into in-
fected neurons. Rather than killing these infected neurons and
causing immunopathology, granzyme B degrades the immedi-
ate early protein ICP4, which is important for viral replication
(Knickelbein et al., 2008). Thus Trm cells might employ multiple
mechanisms to contribute to protective immunity.
Even though Trm cells can directly control infection, Trm cells
might also activate other innate and adaptive leukocytes to pro-
tect the host. For instance, secretion of IFN-g by Trm cells leads892 Immunity 41, December 18, 2014 ª2014 Elsevier Inc.to endothelial upregulation of vascular cell adhesion molecule 1
(VCAM-1), an addressin that draws the recruitment of circulating
memory CD8+ T cells and B cells to sites of Trm cell reactivation
(Schenkel et al., 2014b). Elaboration of IFN-g by Trm cells in the
skin also causes the rapid upregulation of numerous antiviral and
antibacterial genes (Ariotti et al., 2014). And Trm cell reactivation
in the female reproductive tract was shown to precipitate the
maturation of DCs and activation of NK cells in a cytokine-
dependent manner (Schenkel et al., 2014b). Importantly, Trm
cell-dependent activation of parenchymal, innate, and adaptive
immunity triggered the induction of a local protective antiviral
state (Ariotti et al., 2014; Schenkel et al., 2014b).
TLOs (Neyt et al., 2012) and leukocyte aggregates (TLOs have
HEVs, whereas leukocyte aggregates do not) have long been
noted within NLTs. Historically, they have occasionally been
referred to as ectopic lymphoid structures, or abnormal sites of
inflammation. Although more abundant during infection (Crom-
well et al., 2011; Kobayashi et al., 2002;; Zhu et al., 2009), they
are present in healthy humans and to a lesser degree in SPF
mice, which have comparatively little infectious history. TLOs
might comprise inductive sites for immune responses and permit
naive lymphocyte trafficking. On the other hand, leukocyte ag-
gregates contain only Ag-experienced lymphocytes. Leukocyte
aggregates have been characterized in the brain, salivary gland,
lung, female reproductive tract, skin, and liver under a variety of
infectious or inflammatory conditions (Anderson et al., 2014;
Huang et al., 2013; Iijima and Iwasaki, 2014; Natsuaki et al.,
2014; Stahl et al., 2013; Wakim et al., 2010; Walton et al.,
2011). There is considerable variation in the leukocyte popula-
tions found in these aggregates. For instance, aggregates gener-
ated in the vagina of HSV-2-infected mice are composed mostly
ofmacrophages andCD4+ T cells, whereas aggregates that form
in the brain after local vesicular stomatitis virus infection are
composed of CD8+ T cells and CD103+ DCs (Iijima and Iwasaki,
2014; Wakim et al., 2010). Leukocyte aggregates have been pro-
posed to be sites of in situ proliferation in a number of different
models and might also control infections (Huang et al., 2013;
Iijima and Iwasaki, 2014; Natsuaki et al., 2014; Stahl et al.,
2013). Overall, these structures represent a unique niche for
Trm cell function.
CD8+ T cells in NLTs are thus a potent occupying force that is
able to efficiently scan host cells, rapidly purge infection, coloc-
alize with other leukocytes in clusters, and alarm both hemato-
poietic and nonhematopoietic cells to protect the host from
pathogen.
Concluding Remarks
Considerable work has begun to reveal unifying properties of
Trm cells, and these are summarized in Table 1. It is becoming
increasingly clear that Trm cells, which are not assayed by
PBMC sampling, constitute a substantive fraction of the adap-
tive immune system that play a critical role in protective immu-
nity. It is possible that Trm cells might also drive important
disease processes, such as immunopathology and autoimmu-
nity, and could also play an important role in immunosurveillance
of cancer. While recent developments in understanding of Trm
cells are likely to foster new translational opportunities for pro-
phylactic or therapeutic interventions in the contexts of vaccines
or established disease, critical gaps in knowledge remain.





CD103+ Trm cells in many locations are
CD103
CD69+ Some Trm cells may be CD69










Eomeslo Varies by tissue
Function:
Accelerate pathogen control





Parabiosis No T cell equilibration between
parabionts
Transfer of effector vs.
memory T cells
Only effectors migrate to sites of
residence
Crawl out Trm cells fail to crawl out of ex vivo
cultured tissue
Syngeneic tissue grafts No T cell equilibration between graft
and host
FTY720 Treatment does not reposition Trm
cells to SLOs
Transfer male effector T cells
to female mice
Donor cells that become Trm cells
are not rejected




Low homeostatic proliferation Not characterized in many tissues








At least one CD8+ T cell division
in CNS
No CD4+ T cell divisions in
Ag-bearing tail
A summary of the migration assays used to define Trm, and Trm pheno-
typic and transcription factor signatures, proliferation potential, regula-
tion of survival, and functions are shown.
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ReviewAs outlined above, a major challenge for investigations of Trm
cells, particularly in humans, pertains to appropriate sampling
and analytical methods of clinical specimens. The identificationof stable markers and development of new protocols for imaging
Ag-specific T cells within biopsies, particularly from humans of
unknown haplotype, could be essential, particularly for assess-
ing vaccine correlates of protection. There are conceptual chal-
lenges as well, as Trm cells have previously been conflated with
recirculating Tem cells, although these subsets have now taken
on very different meanings. To better exploit Trm cells for protec-
tive immunity via vaccination, the rules for practicably establish-
ing this subset at the desired location will have to be better
defined. In this regard, it will be critical to define the maintenance
requirements and potential longevity of Trm cells within NLTs.
Addressing these issues, and others, might not be straightfor-
ward, because Trm cells might be phenotypically and function-
ally heterogeneous, depending on their location and inducing
stimulus. Althoughmuch remains to be learned, furthering inves-
tigations into Trm cell biology and function are likely to pay div-
idends that can be leveraged for clinical benefit.ACKNOWLEDGMENTS
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